Wauwatosa, WI, United States of America

Marcos Lopez

This inventor holds 6 USPTO granted patents and 2 published patent applications. Top assignees: The Medical College of Wisconsin, Inc., Aix-Marseille Université, Iowa State University Research Foundation Inc.. Active years: 2002-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Marcos Lopez. Retrieved from https://idiyas.com/inventor/marcos-lopez

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 

% Patents Active = 33.3

Average Co-Inventor Count = 3.9

ph-index = 2

Forward Citations = 16(Granted Patents)


Location History:

  • Hialeah, FL (US) (2002)
  • Wauwatosa, WI (US) (2012 - 2013)
  • Floridablanca, CO (2022)

Company Filing History:


Years Active: 2002-2022

Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Inventor Marcos Lopez

Introduction

Marcos Lopez, an accomplished inventor based in Wauwatosa, Wisconsin, has made significant strides in the field of pharmaceutical chemistry. With a remarkable portfolio that includes six patents, his work is primarily focused on developing innovative compounds for medical applications, particularly in the detection and treatment of cancer.

Latest Patents

Among his latest notable inventions are the following patents:

1. **Modified Mito-Metformin Compounds and Methods of Synthesis and Use Thereof**: This invention provides novel mito-metformin compounds, along with pharmaceutical compositions, aimed at using these compounds in cancer treatment.

2. **99m Tc-labeled Triphenylphosphonium Derivative Contrasting Agents and Molecular Probes for Early Detection and Imaging of Breast Tumors**: This patent describes contrasting agents that target mitochondria, facilitating the early detection of breast tumors through scintimammographic imaging. The Tc-Mito-MAG3 compound boasts advantageous radiopharmaceutical properties, with reduced uptake in the myocardium compared to traditional agents like Tc-MIBI, and exhibits rapid blood clearance, enhancing the measurement of signal-to-background ratios.

Career Highlights

Marcos Lopez's career is marked by his contributions to both academia and the pharmaceutical industry. He has been associated with the Medical College of Wisconsin, Inc., where his research efforts have significantly impacted oncology and imaging technologies. His inventive work underlines the application of chemistry in addressing complex medical challenges.

Collaborations

Throughout his career, Marcos Lopez has collaborated with esteemed colleagues such as Micael J. Hardy and Balaraman Kalyanaraman. These collaborations have enriched his research, helping to push the boundaries of what is possible in cancer treatment and imaging methods.

Conclusion

Marcos Lopez stands out in the realm of innovation with his dedication to improving healthcare through his inventive spirit. His latest patents reflect a commitment to advancing medical science, particularly in oncology. As he continues to develop and refine his ideas, the impact of his work promises to enhance diagnostic and therapeutic strategies in cancer treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…